Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039
1 Department of Urology, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute for Urologic Research, Berlin, Germany. Electronic address: carsten.stephan@charite.de.
2 Institute of Medical Informatics, Charité - Universitätsmedizin Berlin, Germany.
3 Department of Urology, Charité - Universitätsmedizin Berlin, Germany; Berlin Institute for Urologic Research, Berlin, Germany.